Bac3Gel is a biotechnology company specialising in advanced biomaterial platforms for gut health applications. Its core innovation centres on a unique mucoadhesive technology designed to improve the delivery and efficacy of live biotherapeutics. This proprietary system overcomes key challenges in microbiome-based therapies by protecting sensitive microorganisms through the harsh gastrointestinal environment. Through partnerships with industry leaders, Bac3Gel provides solutions that enable more accurate preclinical testing and the development of next-generation probiotics and microbial therapies. The company’s focus is on unlocking the full potential of the microbiome to improve human health and wellness.